Cover Image

Utilization and Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists in Posttransplant Diabetes Mellitus in Kidney Transplant Recipients

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Garyn Metoyer, Harriz Z. Whiteson, Yusi Chen, Yiting Li, Chenxi Gao, Gayathri Menon, Sunjae Bae, Krista L. Lentine, Dorry L. Segev, Mara A. McAdams‐DeMarco, Babak J. Orandi
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Clinical Transplantation
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Economic Impact of Dementia After Kidney Transplantation: A Matched Cohort Analysis
by: Krista L. Lentine, et al.
Published: (2025)

Response to Letter to the Editor by Kumar, et al.
by: Babak J. Orandi, et al.
Published: (2026)

Components of Residential Neighborhood Deprivation and Their Impact on the Likelihood of Live‐Donor and Preemptive Kidney Transplantation
by: Yiting Li, et al.
Published: (2024)

Medical Distrust Among Kidney Transplant Candidates
by: Valerie L. Thompson, et al.
Published: (2024)

Sociodemographic disparities in sodium‐glucose cotransporter‐2 inhibitor use among US kidney transplant recipients: An observational study of real‐world pharmacy records
by: Krista L. Lentine, et al.
Published: (2024)

Physical Domains, Access to Kidney Transplantation, and Waitlist Mortality
by: Nan‐Su Huang, et al.
Published: (2025)

Outcomes After Bariatric Surgery in Older Adults With Obesity and End‐Stage Kidney Disease
by: Tanveen Ishaque, et al.
Published: (2025)

Pre‐ and Post‐Kidney Transplant Abdominal Computed Tomography‐Based Muscle Measurements and Post‐KT Outcomes
by: Yi Liu, et al.
Published: (2025)

Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on Proteinuria in Kidney Transplant Recipients
by: Stephanie Shabanowitz, et al.
Published: (2026)

ChatGPT Solving Complex Kidney Transplant Cases: A Comparative Study With Human Respondents
by: Michal A. Mankowski, et al.
Published: (2024)

Glucagon‐Like Peptide‐1 Receptor Agonists: Considerations for Treating Preconception Obesity
by: Lauren T. Berube, et al.
Published: (2026)

Comparing causal parameters with many treatments and positivity violations
by: McClean, Alec, et al.
Published: (2024)

Efficacy, Tolerability, and Safety of Glucagon‐Like Peptide 1 Receptor Agonists (GLP1‐RA) in Kidney Transplant Recipients With Diabetes
by: Henry Zelada, et al.
Published: (2025)

Ensuring the Appropriate Use of Glucagon‐Like Peptide‐1 Receptor Agonists
by: Kenneth Todd Moore, et al.
Published: (2024)

Glucagon‐Like Peptide‐1 Receptor Agonists in Obesity‐Induced Respiratory Pathophysiology
by: Melanie Alexis Ruiz, et al.
Published: (2026)

Effect of Glucagon‐Like Peptide 1 Receptor Agonists on Patients With Rheumatoid Arthritis
by: David A. Kellner, et al.
Published: (2025)

Effect of Glucagon‐Like Peptide 1 Receptor Agonists on Obstructive Sleep Apnea
by: Bei‐Bei Qian, et al.
Published: (2025)

Glucagon‐Like Peptide 1 Receptor Agonists ( GLP ‐ 1RAs ) Improve Periodontal and Peri‐Implant Health in Type 2 Diabetes Mellitus
by: Paras Ahmad, et al.
Published: (2025)

Effect of Glucagon‐Like Peptide‐1 Receptor Agonists on Renal and Cardiovascular Risk Factors in Patients With Type 2 Diabetes Mellitus: A Retrospective Study
by: Daniel Yuan, et al.
Published: (2025)

Association of Glucagon‐Like Peptide‐1 Receptor Agonists and Suicidality: A Systematic Review
by: Hezekiah C. T. Au, et al.
Published: (2026)

Glucagon‐Like Peptide‐1 Receptor Agonists and Anesthesia—Are We Clearer on the Correct Approach?
by: Zachary Bloomgarden
Published: (2024)

Strategies for choosing the best living donor: A review of the literature and a proposal of a decision‐making paradigm
by: Olga Charnaya, et al.
Published: (2024)

The Effects of Glucagon‐Like Peptide‐1 Receptor Agonists on Mitochondrial Function Within Skeletal Muscle: A Systematic Review
by: Victoria J. Old, et al.
Published: (2025)

Impact of Donor Radiographic Pneumonia on Posttransplant Recipient Outcomes and Microbiology
by: Kevin D. He, et al.
Published: (2025)

Review Article: GLP‐1 Receptor Agonists and Glucagon/GIP/GLP‐1 Receptor Dual or Triple Agonists—Mechanism of Action and Emerging Therapeutic Landscape in MASLD
by: Maryam Zafer, et al.
Published: (2025)

Obesity and Female Reproductive Health; Is There a Role for Glucagon‐Like Peptide‐1 Receptor Agonists?
by: Rachel Roberts, et al.
Published: (2025)

Direct or Indirect Action? Mechanisms of the Antiatherosclerotic Effects of Glucagon‐Like Peptide‐1 Receptor Agonists
by: Michał Zawadzki, et al.
Published: (2026)

Glucagon‐Like Peptide‐1 Receptor Agonists in Patients With Durable Left Ventricular Assist Devices
by: Boaz Elad, et al.
Published: (2025)

Glucagon‐Like Peptide‐1 Receptor Agonists Are Associated With Improved Outcomes in Inflammatory Bowel Disease
by: Michael Saadeh, et al.
Published: (2026)

Association Between Glucagon‐Like Peptide‐1 Receptor Agonists and Suicidality: A Systematic Review
by: Timothy H. Chan, et al.
Published: (2026)

Impact of Preoperative Glucagon‐Like Peptide‐1 Receptor Agonist on Outcomes Following Major Surgery
by: Zayed Rashid, et al.
Published: (2025)

Doubly Robust Nonparametric Efficient Estimation for Provider Evaluation
by: Susmann, Herbert, et al.
Published: (2024)

The Association Between Post‐Kidney Transplant Persistent Hyperparathyroidism and Fracture Risk: A Longitudinal Cohort Study
by: Rachel Stemme, et al.
Published: (2026)

Effects of Glucagon‐Like Peptide‐1 Receptor Agonists (Mono and Combination Therapy) on Energy Expenditure: A Scoping Review
by: Flavio T. Vieira, et al.
Published: (2026)

Use of Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study
by: Arvid Engström, et al.
Published: (2026)

Glucagon‐Like Peptide‐1 Receptor Agonists: Are We Swapping One Public Health Crisis for Another?
by: Danielle Ní Chróinín, et al.
Published: (2026)

Asymptotically Efficient Data-adaptive Penalized Shrinkage Estimation with Application to Causal Inference
by: Susmann, Herbert P., et al.
Published: (2025)

Giving children pocket money to help them understand economic principles in personal budget management and reduce gender gaps in financial matters: Does it work?
by: Sharon Garyn‐Tal
Published: (2024)

Glucagon‐Like Peptide‐1 Receptor Agonists Are Associated With Reduced Disease Severity and Pain in Hidradenitis Suppurativa: A Retrospective Study
by: Zahidul Islam, et al.
Published: (2025)

Effects of Glucagon‐Like Peptide‐1 Receptor Agonist on Bone Metabolism and the Expression of Insulin Receptor Substrate 1 in an Osteoporotic Rat Model
by: Yao Ye, et al.
Published: (2026)